ID   NEDD4_RAT               Reviewed;         887 AA.
AC   Q62940;
DT   03-JUL-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   02-OCT-2024, entry version 184.
DE   RecName: Full=E3 ubiquitin-protein ligase NEDD4;
DE            EC=2.3.2.26 {ECO:0000250|UniProtKB:P46934};
DE   AltName: Full=HECT-type E3 ubiquitin transferase NEDD4;
GN   Name=Nedd4; Synonyms=Nedd4a, Rpf1 {ECO:0000250|UniProtKB:P46934};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND INTERACTION WITH SCNN1A; SCNN1B AND SCNN1G.
RC   TISSUE=Lung;
RX   PubMed=8665844; DOI=10.1002/j.1460-2075.1996.tb00593.x;
RA   Staub O., Dho S., Henry P., Correa J., Ishikawa T., McGlade J., Rotin D.;
RT   "WW domains of Nedd4 bind to the proline-rich PY motifs in the epithelial
RT   Na+ channel deleted in Liddle's syndrome.";
RL   EMBO J. 15:2371-2380(1996).
RN   [2]
RP   FUNCTION, INTERACTION WITH RAP2A AND TNIK, SUBCELLULAR LOCATION,
RP   DEVELOPMENTAL STAGE, AND TISSUE SPECIFICITY.
RX   PubMed=20159449; DOI=10.1016/j.neuron.2010.01.007;
RA   Kawabe H., Neeb A., Dimova K., Young S.M. Jr., Takeda M.,
RA   Katsurabayashi S., Mitkovski M., Malakhova O.A., Zhang D.E., Umikawa M.,
RA   Kariya K., Goebbels S., Nave K.A., Rosenmund C., Jahn O., Rhee J.,
RA   Brose N.;
RT   "Regulation of Rap2A by the ubiquitin ligase Nedd4-1 controls neurite
RT   development.";
RL   Neuron 65:358-372(2010).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-212 AND SER-306, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [4]
RP   STRUCTURE BY NMR OF 452-499 IN COMPLEX WITH SCNN1B, AND INTERACTION WITH
RP   SCNN1A; SCNN1B AND SCNN1G.
RX   PubMed=11323714; DOI=10.1038/87562;
RA   Kanelis V., Rotin D., Forman-Kay J.D.;
RT   "Solution structure of a Nedd4 WW domain-ENaC peptide complex.";
RL   Nat. Struct. Biol. 8:407-412(2001).
CC   -!- FUNCTION: E3 ubiquitin-protein ligase which accepts ubiquitin from an
CC       E2 ubiquitin-conjugating enzyme in the form of a thioester and then
CC       directly transfers the ubiquitin to targeted substrates. Specifically
CC       ubiquitinates 'Lys-63' in target proteins (By similarity).
CC       Monoubiquitinates IGF1R at multiple sites, thus leading to receptor
CC       internalization and degradation in lysosomes. Ubiquitinates FGFR1,
CC       leading to receptor internalization and degradation in lysosomes.
CC       Promotes ubiquitination of RAPGEF2. Involved in the pathway leading to
CC       the degradation of VEGFR-2/KDFR, independently of its ubiquitin-ligase
CC       activity. Is involved in ubiquitination of ERBB4 intracellular domain
CC       E4ICD (By similarity). Part of a signaling complex composed of NEDD4,
CC       RAP2A and TNIK which regulates neuronal dendrite extension and
CC       arborization during development (PubMed:20159449). Ubiquitinates TNK2
CC       and regulates EGF-induced degradation of EGFR and TNF2 (By similarity).
CC       Ubiquitinates BRAT1 and this ubiquitination is enhanced in the presence
CC       of NDFIP1 (By similarity). Ubiquitinates DAZAP2, leading to its
CC       proteasomal degradation (By similarity). Ubiquitinates POLR2A (By
CC       similarity). Functions as a platform to recruit USP13 to form an NEDD4-
CC       USP13 deubiquitination complex that plays a critical role in cleaving
CC       the 'Lys-48'-linked ubiquitin chains of VPS34 and then stabilizing
CC       VPS34, thus promoting the formation of autophagosomes (By similarity).
CC       {ECO:0000250|UniProtKB:P46934, ECO:0000250|UniProtKB:P46935,
CC       ECO:0000269|PubMed:20159449}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine +
CC         [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-
CC         cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.;
CC         EC=2.3.2.26; Evidence={ECO:0000250|UniProtKB:P46934};
CC   -!- ACTIVITY REGULATION: Activated by NDFIP1- and NDFIP2-binding.
CC       {ECO:0000250}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Interacts with UBE2D2. Binds, in vitro, through the WW2 and
CC       WW3 domains, to neural isoforms of ENAH that contain the PPSY motif.
CC       Interacts with BEAN1, LITAF, RNF11, WBP1, WBP2, PMEPAI, NDFIP1, and
CC       PRRG2 (By similarity). Interacts (via C2 domain) with GRB10 (via SH2
CC       domain) (By similarity). Binds SCNN1A, SCNN1B and SCNN1G
CC       (PubMed:11323714, PubMed:8665844). Interacts with ERBB4. Interacts with
CC       NDFIP1 and NDFIP2; this interaction activates the E3 ubiquitin-protein
CC       ligase and may induce its recruitment to exosomes (By similarity).
CC       Interacts with TNIK; the interaction is direct, allows the TNIK-
CC       dependent recruitment of RAP2A and its ubiquitination by NEDD4
CC       (PubMed:20159449). Interacts (via WW3 domain) with TNK2; EGF promotes
CC       this interaction. Interacts (via WW3 domain) with FGFR1 (via C-
CC       terminus). Interacts with OTUD7B (By similarity). Interacts with ISG15
CC       (By similarity). Interacts (via WW domain) with RAPGEF2; this
CC       interaction leads to ubiquitination and degradation via the proteasome
CC       pathway. Interacts (via WW domains) with ARRDC3 (via PPXY motifs) (By
CC       similarity). Interacts with LAPTM4B; may play a role in the lysosomal
CC       sorting of LAPTM4B (By similarity). Interacts with ZBTB7B (By
CC       similarity). Interacts with PRRG4 (via cytoplasmic domain) (By
CC       similarity). Interacts directly with LDLRAD3; this interaction promotes
CC       NEDD4 auto-ubiquitination (By similarity). Interacts with ADRB2 (By
CC       similarity). Interacts (via WW domains) with DAZAP2 (via PPAY motif)
CC       (By similarity). {ECO:0000250|UniProtKB:P46934,
CC       ECO:0000250|UniProtKB:P46935, ECO:0000269|PubMed:11323714,
CC       ECO:0000269|PubMed:20159449, ECO:0000269|PubMed:8665844}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:20159449}. Nucleus
CC       {ECO:0000250|UniProtKB:P46934}. Cell membrane
CC       {ECO:0000250|UniProtKB:P46934}; Peripheral membrane protein
CC       {ECO:0000250|UniProtKB:P46934}. Note=Predominantly cytoplasmic but also
CC       located in the nucleus (By similarity). Recruited to the plasma
CC       membrane by GRB10. Once complexed with GRB10 and IGF1R, follows IGF1R
CC       internalization, remaining associated with early endosomes. Uncouples
CC       from IGF1R-containing endosomes before the sorting of the receptor to
CC       the lysosomal compartment (By similarity). May be recruited to exosomes
CC       by NDFIP1 (By similarity). {ECO:0000250|UniProtKB:P46934,
CC       ECO:0000250|UniProtKB:P46935}.
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed. Expression is highest in
CC       lung, kidney and brain. {ECO:0000269|PubMed:20159449}.
CC   -!- DEVELOPMENTAL STAGE: Down-regulated after synapse formation.
CC       {ECO:0000269|PubMed:20159449}.
CC   -!- DOMAIN: The WW domains mediate interaction with PPxY motif-containing
CC       proteins (By similarity). The WW domains mediate interaction with
CC       LITAF, RNF11, WBP1, WBP2, PMEPAI, NDFIP1 and PRRG2 (By similarity).
CC       {ECO:0000250|UniProtKB:P46934, ECO:0000250|UniProtKB:P46935}.
CC   -!- PTM: Undergoes 'Lys-29'-linked auto-ubiquitination at Lys-847 and
CC       serves as a scaffold for recruiting USP13 to form an NEDD4-USP13
CC       deubiquitination complex. {ECO:0000250|UniProtKB:P46934}.
CC   -!- MISCELLANEOUS: A cysteine residue is required for ubiquitin-thioester
CC       formation.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U50842; AAB48949.1; -; mRNA.
DR   PIR; S70642; S70642.
DR   RefSeq; NP_037118.1; NM_012986.1.
DR   PDB; 1I5H; NMR; -; W=452-499.
DR   PDB; 2N8S; NMR; -; A=245-281.
DR   PDB; 2N8T; NMR; -; A=401-437.
DR   PDB; 2N8U; NMR; -; A=401-437.
DR   PDBsum; 1I5H; -.
DR   PDBsum; 2N8S; -.
DR   PDBsum; 2N8T; -.
DR   PDBsum; 2N8U; -.
DR   AlphaFoldDB; Q62940; -.
DR   BMRB; Q62940; -.
DR   SMR; Q62940; -.
DR   BioGRID; 247522; 100.
DR   IntAct; Q62940; 2.
DR   MINT; Q62940; -.
DR   STRING; 10116.ENSRNOP00000074683; -.
DR   iPTMnet; Q62940; -.
DR   PhosphoSitePlus; Q62940; -.
DR   jPOST; Q62940; -.
DR   PaxDb; 10116-ENSRNOP00000063797; -.
DR   PeptideAtlas; Q62940; -.
DR   GeneID; 25489; -.
DR   KEGG; rno:25489; -.
DR   UCSC; RGD:3157; rat.
DR   AGR; RGD:3157; -.
DR   CTD; 4734; -.
DR   RGD; 3157; Nedd4.
DR   eggNOG; KOG0940; Eukaryota.
DR   InParanoid; Q62940; -.
DR   OrthoDB; 5480520at2759; -.
DR   PhylomeDB; Q62940; -.
DR   Reactome; R-RNO-1169408; ISG15 antiviral mechanism.
DR   Reactome; R-RNO-1253288; Downregulation of ERBB4 signaling.
DR   Reactome; R-RNO-8948747; Regulation of PTEN localization.
DR   Reactome; R-RNO-8948751; Regulation of PTEN stability and activity.
DR   Reactome; R-RNO-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   UniPathway; UPA00143; -.
DR   EvolutionaryTrace; Q62940; -.
DR   PRO; PR:Q62940; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005938; C:cell cortex; ISO:RGD.
DR   GO; GO:0000785; C:chromatin; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0043197; C:dendritic spine; ISO:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0005794; C:Golgi apparatus; ISO:RGD.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0005902; C:microvillus; IDA:RGD.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0099524; C:postsynaptic cytosol; ISO:RGD.
DR   GO; GO:0032991; C:protein-containing complex; ISO:RGD.
DR   GO; GO:0000151; C:ubiquitin ligase complex; ISO:RGD.
DR   GO; GO:0031698; F:beta-2 adrenergic receptor binding; ISO:RGD.
DR   GO; GO:0019899; F:enzyme binding; ISO:RGD.
DR   GO; GO:0035255; F:ionotropic glutamate receptor binding; ISO:RGD.
DR   GO; GO:0050815; F:phosphoserine residue binding; ISO:RGD.
DR   GO; GO:0050816; F:phosphothreonine residue binding; ISO:RGD.
DR   GO; GO:0070064; F:proline-rich region binding; ISO:RGD.
DR   GO; GO:0019904; F:protein domain specific binding; ISO:RGD.
DR   GO; GO:0070063; F:RNA polymerase binding; ISO:RGD.
DR   GO; GO:0019871; F:sodium channel inhibitor activity; ISO:RGD.
DR   GO; GO:0043130; F:ubiquitin binding; ISO:RGD.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; ISS:UniProtKB.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IDA:UniProtKB.
DR   GO; GO:0002250; P:adaptive immune response; ISO:RGD.
DR   GO; GO:0048514; P:blood vessel morphogenesis; ISO:RGD.
DR   GO; GO:0034644; P:cellular response to UV; ISO:RGD.
DR   GO; GO:0006974; P:DNA damage response; ISO:RGD.
DR   GO; GO:0003197; P:endocardial cushion development; ISO:RGD.
DR   GO; GO:0051649; P:establishment of localization in cell; ISO:RGD.
DR   GO; GO:0006955; P:immune response; IEP:RGD.
DR   GO; GO:0045087; P:innate immune response; ISO:RGD.
DR   GO; GO:0007041; P:lysosomal transport; ISO:RGD.
DR   GO; GO:0010766; P:negative regulation of sodium ion transport; ISO:RGD.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0030948; P:negative regulation of vascular endothelial growth factor receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0007528; P:neuromuscular junction development; ISO:RGD.
DR   GO; GO:0031175; P:neuron projection development; ISO:RGD.
DR   GO; GO:0042921; P:nuclear receptor-mediated glucocorticoid signaling pathway; ISO:RGD.
DR   GO; GO:0003151; P:outflow tract morphogenesis; ISO:RGD.
DR   GO; GO:0046824; P:positive regulation of nucleocytoplasmic transport; ISO:RGD.
DR   GO; GO:0051897; P:positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; ISO:RGD.
DR   GO; GO:0045732; P:positive regulation of protein catabolic process; ISO:RGD.
DR   GO; GO:0050847; P:progesterone receptor signaling pathway; ISO:RGD.
DR   GO; GO:0070534; P:protein K63-linked ubiquitination; IDA:UniProtKB.
DR   GO; GO:0006513; P:protein monoubiquitination; ISO:RGD.
DR   GO; GO:0006622; P:protein targeting to lysosome; ISO:RGD.
DR   GO; GO:0016567; P:protein ubiquitination; ISS:UniProtKB.
DR   GO; GO:0032801; P:receptor catabolic process; ISO:RGD.
DR   GO; GO:0031623; P:receptor internalization; ISO:RGD.
DR   GO; GO:0048814; P:regulation of dendrite morphogenesis; IDA:UniProtKB.
DR   GO; GO:0042391; P:regulation of membrane potential; ISO:RGD.
DR   GO; GO:0034765; P:regulation of monoatomic ion transmembrane transport; ISO:RGD.
DR   GO; GO:0099149; P:regulation of postsynaptic neurotransmitter receptor internalization; IDA:SynGO.
DR   GO; GO:0099576; P:regulation of protein catabolic process at postsynapse, modulating synaptic transmission; IDA:SynGO.
DR   GO; GO:0050807; P:regulation of synapse organization; ISO:RGD.
DR   GO; GO:0140252; P:regulation protein catabolic process at postsynapse; IDA:SynGO.
DR   GO; GO:0014894; P:response to denervation involved in regulation of muscle adaptation; IEP:RGD.
DR   GO; GO:0006814; P:sodium ion transport; ISO:RGD.
DR   GO; GO:0042110; P:T cell activation; ISO:RGD.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; ISS:UniProtKB.
DR   GO; GO:0043162; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; ISO:RGD.
DR   CDD; cd04033; C2_NEDD4_NEDD4L; 1.
DR   CDD; cd00078; HECTc; 1.
DR   CDD; cd00201; WW; 3.
DR   Gene3D; 2.20.70.10; -; 2.
DR   Gene3D; 2.60.40.150; C2 domain; 1.
DR   Gene3D; 3.30.2160.10; Hect, E3 ligase catalytic domain; 1.
DR   Gene3D; 3.30.2410.10; Hect, E3 ligase catalytic domain; 1.
DR   Gene3D; 3.90.1750.10; Hect, E3 ligase catalytic domains; 1.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR035892; C2_domain_sf.
DR   InterPro; IPR024928; E3_ub_ligase_SMURF1.
DR   InterPro; IPR050409; E3_ubiq-protein_ligase.
DR   InterPro; IPR000569; HECT_dom.
DR   InterPro; IPR035983; Hect_E3_ubiquitin_ligase.
DR   InterPro; IPR001202; WW_dom.
DR   InterPro; IPR036020; WW_dom_sf.
DR   PANTHER; PTHR11254:SF282; E3 UBIQUITIN-PROTEIN LIGASE NEDD4; 1.
DR   PANTHER; PTHR11254; HECT DOMAIN UBIQUITIN-PROTEIN LIGASE; 1.
DR   Pfam; PF00168; C2; 1.
DR   Pfam; PF00632; HECT; 1.
DR   Pfam; PF00397; WW; 3.
DR   PIRSF; PIRSF001569; E3_ub_ligase_SMURF1; 1.
DR   SMART; SM00239; C2; 1.
DR   SMART; SM00119; HECTc; 1.
DR   SMART; SM00456; WW; 3.
DR   SUPFAM; SSF49562; C2 domain (Calcium/lipid-binding domain, CaLB); 1.
DR   SUPFAM; SSF56204; Hect, E3 ligase catalytic domain; 1.
DR   SUPFAM; SSF51045; WW domain; 3.
DR   PROSITE; PS50004; C2; 1.
DR   PROSITE; PS50237; HECT; 1.
DR   PROSITE; PS01159; WW_DOMAIN_1; 3.
DR   PROSITE; PS50020; WW_DOMAIN_2; 3.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Cytoplasm; Isopeptide bond; Membrane;
KW   Neurogenesis; Nucleus; Phosphoprotein; Reference proteome; Repeat;
KW   Transferase; Ubl conjugation; Ubl conjugation pathway.
FT   CHAIN           1..887
FT                   /note="E3 ubiquitin-protein ligase NEDD4"
FT                   /id="PRO_0000120321"
FT   DOMAIN          54..180
FT                   /note="C2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   DOMAIN          246..279
FT                   /note="WW 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00224"
FT   DOMAIN          402..435
FT                   /note="WW 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00224"
FT   DOMAIN          459..492
FT                   /note="WW 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00224"
FT   DOMAIN          551..887
FT                   /note="HECT"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00104"
FT   REGION          214..548
FT                   /note="Mediates interaction with TNIK"
FT                   /evidence="ECO:0000250"
FT   REGION          297..319
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          362..384
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          396..440
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           351..361
FT                   /note="Nuclear export signal"
FT                   /evidence="ECO:0000250|UniProtKB:P46934"
FT   COMPBIAS        422..436
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        854
FT                   /note="Glycyl thioester intermediate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00104"
FT   MOD_RES         212
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         284
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P46935"
FT   MOD_RES         306
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         377
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P46934"
FT   MOD_RES         382
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P46934"
FT   CROSSLNK        847
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:P46934"
FT   STRAND          252..256
FT                   /evidence="ECO:0007829|PDB:2N8S"
FT   STRAND          262..266
FT                   /evidence="ECO:0007829|PDB:2N8S"
FT   TURN            267..269
FT                   /evidence="ECO:0007829|PDB:2N8S"
FT   STRAND          272..275
FT                   /evidence="ECO:0007829|PDB:2N8S"
FT   STRAND          401..404
FT                   /evidence="ECO:0007829|PDB:2N8T"
FT   STRAND          408..412
FT                   /evidence="ECO:0007829|PDB:2N8T"
FT   STRAND          414..416
FT                   /evidence="ECO:0007829|PDB:2N8U"
FT   STRAND          418..422
FT                   /evidence="ECO:0007829|PDB:2N8T"
FT   TURN            423..426
FT                   /evidence="ECO:0007829|PDB:2N8T"
FT   STRAND          427..429
FT                   /evidence="ECO:0007829|PDB:2N8U"
FT   STRAND          454..456
FT                   /evidence="ECO:0007829|PDB:1I5H"
FT   STRAND          465..469
FT                   /evidence="ECO:0007829|PDB:1I5H"
FT   STRAND          475..479
FT                   /evidence="ECO:0007829|PDB:1I5H"
FT   TURN            480..483
FT                   /evidence="ECO:0007829|PDB:1I5H"
FT   STRAND          484..488
FT                   /evidence="ECO:0007829|PDB:1I5H"
FT   TURN            490..492
FT                   /evidence="ECO:0007829|PDB:1I5H"
SQ   SEQUENCE   887 AA;  102395 MW;  D74B1097688CD9A1 CRC64;
     MAADDTEAPV LSEDEVWEFC LDKNEEGGGS PGSDVTDTCE PPCGCWELNP SSLEEEHVLF
     TAESIISSFN NDDTRVVRVK VIAGIGLAKK DILGASDPYV RVTLYDPMSG VLTSVQTKTI
     KKSLNPKWNE EILFRVLPQQ HRILFEVFDE NRLTRDDFLG QVDVPLYPLP TENPRMERPY
     TFKDFVLHPR SHKSRVKGYL RLKMTYLPKN GSDDENADQA EELEPGWVVL DQPDAATHLQ
     HPPEPSPLPP GWEERQDVLG RTYYVNHESR TTQWKRPSPE DDLTDDENGD IQLQAHGAFT
     TRRQISEDVD GPDNHESPEN WEIVREDENT IYSGQAVQSP PSGHPDVQVR LAEELDTRLT
     MYGNPATSQP VTSSNHSSRG GSSQTCIFEE QPTLPVLLPT SSGLPPGWEE KQDDRGRSYY
     VDHNSKTTTW SKPTMQDDPR SKIPAHLRGK TPVDSNDLGP LPPGWEERTH TDGRVFFINH
     NIKKTQWEDP RMQNVAITGP AEPYSRDYKR KYEFFRRKLK KQTDIPNKFE MKLRRANILE
     DSYRRIMGVK RADFLKARLW IEFDGEKGLD YGGVAREWFF LISKEMFNPY YGLFEYSATE
     DNYTLQINPN SGLCNEDHLS YFKFIGRVAG MAVYHGKLLD GFFIRPFYKM MLQKLITLHD
     MESVDSEYYS SLRWILENDP TELDLRFIID EELFGQTHQH ELKTGGSEVV VTNKNKKEYI
     YLVIQWRFVN RIQKQMAAFK EGFFELIPQD LIKIFDENEL ELLMCGLGDV DVNDWREHTK
     YKNGYSLNHQ VIHWFWKAVL MMDSEKRIRL LQFVTGTSRV PMNGFAELYG SNGPQSFTVE
     QWGTPDKLPR AHTCFNRLDL PPYESFDELW DKLQMAIENT QGFDGVD
//
